Appointment of Independent Director in the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare Limited held a board meeting on May 30, 2025, where it approved the appointment of Ms. Krupalibahen Rajeshbhai Mehta (DIN: 11109785) as an Additional Non-Executive, Independent Director for a 5-year term, subject to shareholder approval. Ms. Mehta holds no shareholding in the company, is not related to any existing Director, KMP, or Promoter, and has no other listed-entity directorships. The Board also approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2025. Notably, the auditor's report on these results is a qualified report, and the company has attached a Statement on Impact of Audit Qualifications.
The appointment strengthens the board with an additional independent director, which is generally positive for governance. However, shareholders should note the qualified auditor report on the FY25 results, which signals a potential area of concern in the financial statements that warrants closer review.